Literature DB >> 15488560

Investigation of thyroid, head, and neck cancers with PET.

Hongming Zhuang1, Rakesh Kumar, Susan Mandel, Abass Alavi.   

Abstract

PET with [(18)F]-fluorodeoxyglucose (FDG) has been accepted as a useful imaging modality for the diagnosis of a variety of malignancies. This article discusses the use of FDG-PET in the management of patients with thyroid and head or neck cancers.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15488560     DOI： 10.1016/j.rcl.2004.07.006

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN： 0033-8389            Impact factor:   2.303


  4 in total

Review 1.  (18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.

Authors:  Gianpiero Manca; Eleonora Vanzi; Domenico Rubello; Francesco Giammarile; Gaia Grassetto; Ka Kit Wong; Alan C Perkins; Patrick M Colletti; Duccio Volterrani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-19       Impact factor: 9.236

Review 2.  Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Rakesh Kumar; Sandip Basu; Drew Torigian; Vivek Anand; Hongming Zhuang; Abass Alavi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

3.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Authors:  Akram Al-Ibraheem; Andreas Buck; Bernd Joachim Krause; Klemens Scheidhauer; Markus Schwaiger
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375

4.  Diffusely increased thyroidal uptake of F-18 fluorodeoxyglucose in a patient with non-Hodgkin's lymphoma and Graves' disease.

Authors:  Koramadai Karuppuswamy Kamaleshwaran; Raghav Kashyap; Chidambaram Natarajan Balasubramaniam Harisankar; Anish Bhattacharya; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2012-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.